Adherence to antiretroviral treatment in patients with HIV in the UK
A study of complexity
Bibliographic Data
Adherence to HIV treatment regimes is a core element to viral suppression. Yet measurement of adherence is complex. Although adherence levels are good predictors of outcome, they do not always provide full explanations of observed variations in responses. This study was set up to examine the complexity of adherence measurement and to examine rates of adherence in the presence of complex measurement. A total of 502 consecutive attenders at HIV clinics in the UK (80.5% response rate) provided detailed measurement on adherence in the preceding 7 days, setting out dose adherence, as well as measures of timing and dietary conditions. In addition, a range of psychological, demographic and relationship data were gathered to understand predictors of full and partial adherence. Although 79.1% reported dose adherence in the previous 7 days, 42.8% had not taken the dose at the correct time, and 27.2% had not taken the dose under the correct circumstances. Using a more complex composite measure of full adherence, rates reduced from 79.1% to 41.5%. Comparisons of those deemed fully adherent, partially adherent and non-adherent were carried out. Those that were fully adherent were significantly more likely to be older (F=7.8, p<0.001), UK born (F=6.8, p=0.03), code ethnicity as white (F=5.3, p=0.07), record higher quality of life (chi(2)=8.7, p=0.01), lower psychological symptoms (chi(2)=15.2, p=0.001) and lower global distress symptoms (chi(2)=6.9, p=0.03). There were no differences according to education, behavioural and attitudinal variables (disclosure, stable relationship, STI diagnosed, number of sexual partners, unprotected sex, optimism or treatment switching). Fully adherent groups were significantly more likely to be in agreement with their doctor on treatment initiation (chi(2)=6.2, p=0.045), satisfied with the amount of involvement in the decision-making process (chi(2)=7.3, p=.026), their wishes were considered (chi(2)=12.5, p=0.002) and had monitoring of their condition (chi(2)=7.1, p=0.028). Multivariate analysis showed that variables which contributed significantly at a 5% criterion level to complex adherence were physical symptoms (OR=0.56, p=0.05), psychological symptoms (OR=2.37, p<0.001), age (OR=0.96, p=0.02), education (OR=0.54, p=0.03), having more than one sexual partner (OR=0.46, p=0.03), having risky sex (OR=4.30, p=0.002) and being optimistic about treatments (OR=0.42, p=0.01). The softer markers of adherence are not usually measured in follow up and may account for variations in treatment responses. The complexity of adherence needs to be understood and addressed to maximise treatment efficacy
Anxiety · Distress · Ethnic group · Psychiatry · Psychological distress · Clinical Psychology · Demography · HIV/AIDS drug development and treatment · HIV/AIDS Research and Interventions · LGBTQ Health, Identity, and Policy · Medicine · Gerontology · Immunology · Internal Medicine
Where's the Care
Predictors and correlates of adherence to combination antiretroviral therapy (ART) for chronic HIV infection
HIV and Depression – a systematic review of interventions
Does sexual behaviour of people with HIV reflect antiretroviral therapy as a preventive strategy? A cross-sectional study among outpatients in Kenya
Understanding how adherence goals promote adherence behaviours
Non-Disclosure of HIV Status and Associations with Psychological Factors, ART Non-Adherence, and Viral Load Non-Suppression Among People Living with HIV in the UK
Non-Disclosure of a Pregnant Woman’s HIV Status to Her Partner is Associated with Non-Optimal Prevention of Mother-to-Child Transmission
Novel Approaches for Visualizing and Analyzing Dose-Timing Data from Electronic Drug Monitors, or “How the ‘Broken Window’ Theory Pertains to ART Adherence”
Symptom prevalence, burden and correlates among people living with HIV in Vietnam
A novel symptom cluster analysis among ambulatory HIV/Aids patients in Uganda
Is symptom prevalence and burden associated with HIV treatment status and disease stage among adult HIV outpatients in Kenya? A cross-sectional self-report study
What factors are associated with patient self-reported health status among HIV outpatients? A multi-centre UK study of biomedical and psychosocial factors
Prevalence and correlates of emotional distress in HIV/HCV coinfection
Self-reported non-adherence to ART and virological outcome in a multiclinic UK study
Burden and risk factors for gastrointestinal symptom distress in HIV patients in the modern antiretroviral era
Stakeholders' perspectives and requirements on pain self-management for adolescents living with HIV/Aids in Malawi
Prevalence of pain in women living with HIV aged 45–60
Understanding HIV disclosure
Efficacy of Interventions in Improving Highly Active Antiretroviral Therapy Adherence and HIV-1 RNA Viral Load
Stress, Social Support, and HIV-Status Disclosure to Family and Friends Among HIV-Positive Men and Women
Adherence to Antiretroviral Therapy in Sub-Saharan Africa and North America
Adherence to Protease Inhibitor Therapy and Outcomes in Patients with HIV Infection
Adherence - sticking to the evidence
Adherence to HIV combination therapy
| Unique citing works | 18 |
|---|---|
| Citations per year | 1,13 |
| Citation span | 2010 - 2023 (14) |
| Citation velocity | historical |
| Highly cited | No |
| Citation types | Neutral: 17 |